These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30365949)

  • 41. Antiviral Drugs Against Alphaherpesvirus.
    Shiraki K
    Adv Exp Med Biol; 2018; 1045():103-122. PubMed ID: 29896665
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antiviral drug resistance and helicase-primase inhibitors of herpes simplex virus.
    Field HJ; Biswas S
    Drug Resist Updat; 2011 Feb; 14(1):45-51. PubMed ID: 21183396
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Superior efficacy of helicase-primase inhibitor BAY 57-1293 for herpes infection and latency in the guinea pig model of human genital herpes disease.
    Baumeister J; Fischer R; Eckenberg P; Henninger K; Ruebsamen-Waigmann H; Kleymann G
    Antivir Chem Chemother; 2007; 18(1):35-48. PubMed ID: 17354650
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Integrative pharmacokinetic-pharmacodynamic modeling and simulation of amenamevir (ASP2151) for treatment of recurrent genital herpes.
    Takada A; Katashima M; Kaibara A; Chono K; Katsumata K; Sawamoto T; Suzuki H; Yano Y
    Drug Metab Pharmacokinet; 2016 Aug; 31(4):323-32. PubMed ID: 27461507
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Influence of Hepatic and Renal Impairment on the Pharmacokinetics of a Treatment for Herpes Zoster, Amenamevir (ASP2151): Phase 1, Open-Label, Single-Dose, Parallel-Group Studies.
    Kusawake T; Kowalski D; Takada A; Kato K; Katashima M; Keirns JJ; Lewand M; Lasseter KC; Marbury TC; Preston RA
    Adv Ther; 2017 Dec; 34(12):2612-2624. PubMed ID: 29134428
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Drugs in development for herpes simplex and varicella zoster virus.
    Birkmann A; Zimmermann H
    Clin Pharmacol Ther; 2017 Jul; 102(1):30-32. PubMed ID: 28160282
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Potent in vivo antiviral activity of the herpes simplex virus primase-helicase inhibitor BAY 57-1293.
    Betz UA; Fischer R; Kleymann G; Hendrix M; Rübsamen-Waigmann H
    Antimicrob Agents Chemother; 2002 Jun; 46(6):1766-72. PubMed ID: 12019088
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacokinetics-pharmacodynamics of the helicase-primase inhibitor pritelivir following treatment of wild-type or pritelivir-resistant virus infection in a murine herpes simplex virus 1 infection model.
    Biswas S; Sukla S; Goldner T; Field HJ; Kropeit D; Paulsen D; Welbers A; Ruebsamen-Schaeff H; Zimmermann H; Birkmann A
    Antimicrob Agents Chemother; 2014 Jul; 58(7):3843-52. PubMed ID: 24752278
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antiviral drugs for varicella-zoster virus and herpes simplex virus infections.
    Med Lett Drugs Ther; 2018 Sep; 60(1556):153-157. PubMed ID: 30383727
    [No Abstract]   [Full Text] [Related]  

  • 50. Pharmacokinetics and Dialyzability of a Single Oral Dose of Amenamevir, an Anti-Herpes Drug, in Hemodialysis Patients.
    Tsuruoka S; Endo T; Seo M; Hashimoto N
    Adv Ther; 2020 Jul; 37(7):3234-3245. PubMed ID: 32440976
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antiviral activity of PHA767491 against human herpes simplex virus in vitro and in vivo.
    Hou J; Zhang Z; Huang Q; Yan J; Zhang X; Yu X; Tan G; Zheng C; Xu F; He S
    BMC Infect Dis; 2017 Mar; 17(1):217. PubMed ID: 28320320
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The DNA helicase-primase complex as a target for herpes viral infection.
    Weller SK; Kuchta RD
    Expert Opin Ther Targets; 2013 Oct; 17(10):1119-32. PubMed ID: 23930666
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Herpes simplex virus helicase-primase inhibitors: recent findings from the study of drug resistance mutations.
    Biswas S; Field HJ
    Antivir Chem Chemother; 2008; 19(1):1-6. PubMed ID: 18610552
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Amenamevir, a novel helicase-primase inhibitor, for treatment of herpes zoster: A randomized, double-blind, valaciclovir-controlled phase 3 study.
    Kawashima M; Nemoto O; Honda M; Watanabe D; Nakayama J; Imafuku S; Kato T; Katsuramaki T;
    J Dermatol; 2017 Nov; 44(11):1219-1227. PubMed ID: 28681394
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The helicase primase inhibitor, BAY 57-1293 shows potent therapeutic antiviral activity superior to famciclovir in BALB/c mice infected with herpes simplex virus type 1.
    Biswas S; Jennens L; Field HJ
    Antiviral Res; 2007 Jul; 75(1):30-5. PubMed ID: 17175035
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Efficacy of Amenamevir for the Treatment of Disseminated Herpes Zoster Complicated with Probable Varicella-zoster Pneumonia in an Immunocompromised Patient.
    Kobayashi H; Yoshida Y; Komoshita T; Suma H; Hosokawa Y; Hirose Y; Sugimoto T; Mokuda S; Hirata S; Sugiyama E
    Intern Med; 2022 Jun; 61(11):1785-1788. PubMed ID: 34776482
    [TBL] [Abstract][Full Text] [Related]  

  • 57. New helicase-primase inhibitors as drug candidates for the treatment of herpes simplex disease.
    Kleymann G; Fischer R; Betz UA; Hendrix M; Bender W; Schneider U; Handke G; Eckenberg P; Hewlett G; Pevzner V; Baumeister J; Weber O; Henninger K; Keldenich J; Jensen A; Kolb J; Bach U; Popp A; Mäben J; Frappa I; Haebich D; Lockhoff O; Rübsamen-Waigmann H
    Nat Med; 2002 Apr; 8(4):392-8. PubMed ID: 11927946
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A short commentary on the review by Weller and Kuchta: the DNA helicase-primase complex as a target for herpes virus infection.
    Field HJ
    Expert Opin Ther Targets; 2013 Oct; 17(10):1113-4. PubMed ID: 24044544
    [No Abstract]   [Full Text] [Related]  

  • 59. The comparative effects of famciclovir and valacyclovir on herpes simplex virus type 1 infection, latency, and reactivation in mice.
    LeBlanc RA; Pesnicak L; Godleski M; Straus SE
    J Infect Dis; 1999 Sep; 180(3):594-9. PubMed ID: 10438344
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Absorption, Distribution, Metabolism, and Excretion of the Novel Helicase-Primase Inhibitor, Amenamevir (ASP2151), in Rodents.
    Ohtsu Y; Susaki Y; Noguchi K
    Eur J Drug Metab Pharmacokinet; 2018 Dec; 43(6):693-706. PubMed ID: 29748821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.